May 28 - The U.S. FDA's advisory panel will vote on Thursday on whether COVID-19 vaccines for the 2026-2027 immunization campaign should target the dominant XFG variant, after staff members raised concerns about limited data on currently circulating strains.
Dailyhunt
Disclaimer: This content has not been generated, created or edited by Dailyhunt. Publisher: Straitstimes